微小RNA-433在运动改善心肌梗死后心室重构中的作用和机制

基本信息
批准号:81472158
项目类别:面上项目
资助金额:61.00
负责人:车琳
学科分类:
依托单位:同济大学
批准年份:2014
结题年份:2018
起止时间:2015-01-01 - 2018-12-31
项目状态: 已结题
项目参与者:严文文,毛玉,赵丽娟,闻思婉,李泽清,刘忠柳
关键词:
微小RNA运动重构心肌梗死
结项摘要

Myocardial infarction (MI) is a serious disease worldwide. Even with an early reperfusion therapy, the patients will still suffer from cardiac remodeling post-infarction, which also seriously affected the quality of life. Unfortunately, no therapy in the clinic can cure the remodeling post-MI. Exercise training has been widely used to benefit the patients after MI, however, the molecular mechanism is unclear. MicroRNAs (miRNAs, miRs) regulate cardiac physiological and pathological processes. Our preliminary data have demonstrated that exercise protected cardiac remodeling post-MI. Moreover, based on miRNA arrays and quantitative reverse transcriptase-polymerase chain reactions, we found that miR-433 was significantly down-regulated in AMI mouse than that of control mouse, and it could be restored by exercise. In addition, elevated miR-433 can protect apoptosis and necrosis caused by anoxia/reoxygention. Based on these results, we will firstly identify the role of miR-433 in the protective effects of exercise in cardiac remodeling post-MI. Secondly, we will investigate the potential target gene of miR-433 responsible for the protective effects by gene array, bioinformatic analysis, and the rescue experiments both in vitro and in vivo. Our project will identify a miRNA mediating the protective role of exercise in cardiac remodeling post-MI and will provide a novel therapeutic strategy for the treatment of ventricular remodeling post-MI.

心肌梗死是人类致死致残率极高的重大疾病之一,即使得到及时救治,心肌梗死后的心室重构同样严重影响患者的生存质量。目前临床上尚无针对心肌梗死后心室重构的特效治疗策略。运动康复发现有利于心肌梗死后心室重构,但其分子机制尚不清楚。我们的前期工作发现,运动能改善心肌梗死后心室重构。利用微小RNA芯片和荧光定量PCR技术发现,微小RNA-433在心肌梗死28天后的心脏中显著下调,且这一现象可被运动所逆转,增加微小RNA-433可减轻心肌细胞系缺氧复氧所致凋亡和坏死,提示该微小RNA433可能是运动防治心肌梗死后心室重构的关键分子。在此基础上,我们将进一步应用药物干预和转基因模式动物,结合分子、细胞及动物整体层面的研究,开展功能获得性和缺失性实验,从多层面多角度深入探讨微小RNA-433对心肌梗死后心室重构的防治效应及其分子基础,为心肌梗死后心室重构的治疗提供新的可能方案。

项目摘要

心肌梗死是人类致死致残率极高的重大疾病之一,即使得到及时救治,心肌梗死后的心室重构同样严重影响患者的生存质量。目前临床上尚无针对心肌梗死后心室重构的特效治疗策略。本研究项目首先从动物水平心肌梗死所致的心室重构模型和成纤维水平TGFβ刺激模型中,发现miR-433的表达显著性升高;然后通过在细胞水平升高和降低miR-433的表达,发现高表达miR-433能够促进成纤维细胞的激活,而抑制miR-433能够抑制TGFβ导致成纤维细胞的激活。接着,我们鉴定出了miR-433介导纤维化发生的下游靶基因:AZIN1。最后,我们明确miR-433通过抑制AZIN1后,激活TGFβ-Smad3信号通路介导纤维化的发生的。本课题鉴定出一个心脏纤维化的关键微小RNA-miR-433,并开发出一种新的防治心脏纤维化的方法。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

DOI:10.16476/j.pibb.2019.0092
发表时间:2019
2

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

DOI:https://doi.org/10.1007/s11427-018-9450-1
发表时间:2019
3

精子相关抗原 6 基因以非 P53 依赖方式促进 TRAIL 诱导的骨髓增生异常综合征 细胞凋亡

精子相关抗原 6 基因以非 P53 依赖方式促进 TRAIL 诱导的骨髓增生异常综合征 细胞凋亡

DOI:
发表时间:2018
4

下调SNHG16对胃癌细胞HGC-27细胞周期的影响

下调SNHG16对胃癌细胞HGC-27细胞周期的影响

DOI:
发表时间:2017
5

A novel promoter-associated non-coding small RNA paGLI1 recruits FUS/ P65 to transactivate GLI1 gene expression and promotes infiltrating glioma progression

A novel promoter-associated non-coding small RNA paGLI1 recruits FUS/ P65 to transactivate GLI1 gene expression and promotes infiltrating glioma progression

DOI:10.1016/j.canlet.2022.01.016
发表时间:2022

车琳的其他基金

相似国自然基金

1

MicroRNA在反复肢体缺血后适应改善心肌梗死后心室重构中的功能及调控机制研究

批准号:81873953
批准年份:2018
负责人:王甲莉
学科分类:H1602
资助金额:57.00
项目类别:面上项目
2

MicroRNA-133在丹参酮Ⅱ-A改善左心室重构/心力衰竭中的作用和机制研究

批准号:81202825
批准年份:2012
负责人:冯俊
学科分类:H3302
资助金额:23.00
项目类别:青年科学基金项目
3

心肌高表达mi-99a改善心肌梗死后心室重构及其机制研究

批准号:81200092
批准年份:2012
负责人:顾蓉
学科分类:H0202
资助金额:23.00
项目类别:青年科学基金项目
4

TRAF1在心肌梗死后心室重构中的作用及分子机制

批准号:81370264
批准年份:2013
负责人:朱学海
学科分类:H0202
资助金额:70.00
项目类别:面上项目